162 related articles for article (PubMed ID: 7934410)
1. Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin.
Lynn WA; Clutterbuck E; Want S; Markides V; Lacey S; Rogers TR; Cohen J
Lancet; 1994 Oct; 344(8928):1025-6. PubMed ID: 7934410
[No Abstract] [Full Text] [Related]
2. Vancomycin-resistant Enterococcus faecium osteomyelitis: successful treatment with quinupristin-dalfopristin.
Summers M; Misenhimer GR; Antony SJ
South Med J; 2001 Mar; 94(3):353-5. PubMed ID: 11284529
[TBL] [Abstract][Full Text] [Related]
3. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
Winston DJ; Emmanouilides C; Kroeber A; Hindler J; Bruckner DA; Territo MC; Busuttil RW
Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685
[TBL] [Abstract][Full Text] [Related]
4. Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species.
Cormican MG; Johnson DM; Jones RN
Diagn Microbiol Infect Dis; 1996 Jan; 24(1):59-60. PubMed ID: 8988766
[No Abstract] [Full Text] [Related]
5. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort.
Linden PK; Pasculle AW; McDevitt D; Kramer DJ
J Antimicrob Chemother; 1997 May; 39 Suppl A():145-51. PubMed ID: 9511079
[TBL] [Abstract][Full Text] [Related]
6. Glycopeptide-resistant Enterococcus faecium infections in paediatric liver transplant recipients: safety and clinical efficacy of quinupristin/dalfopristin.
Verma A; Dhawan A; Philpott-Howard J; Rela M; Heaton N; Vergani GM; Wade J
J Antimicrob Chemother; 2001 Jan; 47(1):105-8. PubMed ID: 11152440
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group.
Moellering RC; Linden PK; Reinhardt J; Blumberg EA; Bompart F; Talbot GH
J Antimicrob Chemother; 1999 Aug; 44(2):251-61. PubMed ID: 10473233
[TBL] [Abstract][Full Text] [Related]
8. Quinupristin-dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: efficacy and development of resistance.
Chong YP; Lee SO; Song EH; Lee EJ; Jang EY; Kim SH; Choi SH; Kim MN; Jeong JY; Woo JH; Kim YS
Scand J Infect Dis; 2010 Jul; 42(6-7):491-9. PubMed ID: 20524781
[TBL] [Abstract][Full Text] [Related]
9. Case of vancomycin-resistant Enterococcus faecium infection associated with a transjugular intrahepatic portosystemic shunt that was treated with quinupristin/dalfopristin after bacteremia persisted with alatrofloxacin therapy.
Zaman MM; Recco R; Tejwani U; Scuto TJ; Ahmed S; Hypolite A; Jayaraman G
Clin Infect Dis; 1999 Oct; 29(4):954-5. PubMed ID: 10589932
[No Abstract] [Full Text] [Related]
10. Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns.
Furlong WB; Rakowski TA
Clin Infect Dis; 1997 Jul; 25(1):163-4. PubMed ID: 9243059
[No Abstract] [Full Text] [Related]
11. Peritoneal dialysis-related peritonitis caused by vancomycin-resistant Enterococcus faecium.
Unal A; Agkus C; Kocyigit I; Oymak O; Utas C
Ther Apher Dial; 2011 Feb; 15(1):115-6. PubMed ID: 21272263
[No Abstract] [Full Text] [Related]
12. Treatment of vancomycin-resistant Enterococcus faecium infections.
Lai KK
Arch Intern Med; 1996 Dec 9-23; 156(22):2579-84. PubMed ID: 8951301
[TBL] [Abstract][Full Text] [Related]
13. Quinupristin/dalfopristin in neonatal Enterococcus faecium meningitis.
Gransden WR; King A; Marossy D; Rosenthal E
Arch Dis Child Fetal Neonatal Ed; 1998 May; 78(3):F235-6. PubMed ID: 9713046
[No Abstract] [Full Text] [Related]
14. Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia.
Chow JW; Donahedian SM; Zervos MJ
Clin Infect Dis; 1997 Jan; 24(1):90-1. PubMed ID: 8994759
[No Abstract] [Full Text] [Related]
15. Successful treatment of vancomycin-resistant enterococcal peritonitis with linezolid in a kidney transplant patient: a case report and review of the literature.
Tedla FM; Salifu M; Friedman EA
Perit Dial Int; 2004; 24(1):70-2. PubMed ID: 15104340
[No Abstract] [Full Text] [Related]
16. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
17. RP59500 (Quinupristin/dalfopristin): three case reports of its use in infection due to Enterococcus faecium.
Cassell J; Balakrishnan I; Samarasinghe D; Mistry P; Prentice HG; Gillespie SH
J Infect; 1998 May; 36(3):324-7. PubMed ID: 9661946
[TBL] [Abstract][Full Text] [Related]
18. Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection.
Tush GM; Huneycutt S; Phillips A; Ward JD
Clin Infect Dis; 1998 Jun; 26(6):1460-1. PubMed ID: 9636880
[No Abstract] [Full Text] [Related]
19. Quinupristin/dalfopristin, a new addition to the antimicrobial arsenal.
Johnson AP; Livermore DM
Lancet; 1999 Dec; 354(9195):2012-3. PubMed ID: 10636359
[No Abstract] [Full Text] [Related]
20. Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature.
Tan TY; Pitman I; Penrose-Stevens A; Simpson BA; Flanagan PG
J Infect; 2000 Jul; 41(1):95-7. PubMed ID: 11041712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
